· rebuilt nightly from public records
Signal Sheet
Lisata Therapeutics is a listed pharmaceutical preparations company in Basking Ridge, New Jersey. It raised $351.9M in Sep 2026 and its filings name 9 officers. Everything below links to the record it came from.
Officer or director change
New leadershipEquity raise reported to the SEC, Sep 2026.
CapitalSigned a material agreement
Corporate eventPick the companies and territory you sell to and get dated, sourced reasons like these for each one, ranked by who is most likely to buy now. Your list stays yours.
Want this matched to what you sell? Get early access to Pursuit Plans →The most recent events first, refreshed every night. Each links to the record it came from.
| When | What happened | Kind | Source |
|---|---|---|---|
| Oct 13, 2026 | Officer or director change | New leadership | SEC filing |
| Sep 17, 2026 | Raised $351.9M in equity from 20 investors | Capital | SEC filing |
| Sep 17, 2026 | Signed a material agreement | Corporate event | SEC filing |
| Sep 17, 2026 | Completed an acquisition or sale | Corporate event | SEC filing |
| Sep 17, 2026 | Officer or director change | New leadership | SEC filing |
| Aug 3, 2026 | Officer or director change | New leadership | SEC filing |
| Aug 3, 2026 | Announced exit or restructuring costs | Corporate event | SEC filing |
| Jul 16, 2026 | Signed a material agreement | Corporate event | SEC filing |
The roles that matter for a seller right now. Names on this page come from SEC filings or the company's own announcements. Contacts you find with a free trial are verified before you see them. How we source names
| Role | Contact | Source | Why they matter now |
|---|---|---|---|
| Executive Officer | David Mazzo | SEC filing, Sep 2026 | Named officer in the filing; part of the buying group |
| Executive Officer | James Nisco | SEC filing, Sep 2026 | Named officer in the filing; part of the buying group |
| Executive Officer | Tariq Imam | SEC filing, Sep 2026 | Named officer in the filing; part of the buying group |
| Chief Technology Officer | Gregory Brown | SEC filing, Sep 2026 | Technology and tooling decisions |
| Chief Technology Officer | Heidi Henson | SEC filing, Sep 2026 | Technology and tooling decisions |
| Chief Technology Officer | Cynthia Flowers | SEC filing, Sep 2026 | Technology and tooling decisions |
| Chief Technology Officer | Steven Klosk | SEC filing, Sep 2026 | Technology and tooling decisions |
| Chief Technology Officer | Mohammad Azab | SEC filing, Sep 2026 | Technology and tooling decisions |
| Chief Technology Officer | Ted Love | SEC filing, Sep 2026 | Technology and tooling decisions |
Lakewave does the research, the stitching and the first draft with AI, so you spend your time selling.
Lakewave tracks raises, new leaders, hiring and filings across your accounts and territory, and tells you the day something changes.
Find the decision makers, get mailbox-verified addresses and an AI draft written for that account, which you review. Send from your own inbox with open and reply tracking and a follow-up sequence.
Which accounts to pursue, why now, who to reach and what to say, matched to your product and the buyers you sell to.
Every address Lakewave gives you is checked against Lisata Therapeutics's mail server before you see it. Guessed addresses bounce, and bounces are what push a sender's domain toward the spam folder, so one bad list can cost a rep weeks of deliverability. Lakewave shows how each address was confirmed and leaves out the ones it cannot verify.
Use it two ways. Look up the verified address you need for a call you are already planning. Or let Lakewave do the whole job: find the accounts with a reason to buy now, the right people and their addresses, and draft a first email for each person, so you are not stitching together data sources and research by hand.
Try it on Lisata Therapeutics with a free trial →| Headquarters | Basking Ridge, New Jersey, per the filing address |
| Industry group | Pharmaceutical Preparations |
| Ownership | Listed company |
| Raise history | $351.9M (Sep 2026) |
| Lakewave Rising | 44 · 3 kinds of evidence · rank in New Jersey after sign-up |
Private-sector companies in the same industry group and state, ranked by Rising score.
Yes. Lisata Therapeutics reported a $351.9M equity raise to the SEC on Sep 17, 2026 with 20 investors.
The company's SEC filing, Sep 2026 names David Mazzo (Executive Officer) among its officers.
Basking Ridge, New Jersey, per the address on its SEC filing.
Select the accounts and territory you sell to and get dated reasons for every company: new budget, new leaders, new hires, with who to reach and a first draft for each contact.
Start your free trialEvery account you select comes back scored by what changed this month, with the source for each fact.
Named officers from filings and announcements, each with an address verified against the mailbox. No bounces, no guessed patterns, no scraped profiles.
Lakewave writes a first email for each person, tailored to their role and company. You edit, approve and send it from your own mailbox.
A weekly note on what changed across your targets, so no account moves without you knowing.
Free trial · No credit card · Built from public records, refreshed nightly
Compiled from public records and refreshed nightly; last updated Nov 10, 2026. Facts are as the SEC, the company's careers page or the company's own announcements published them. Check the source before acting. See something wrong? Tell us and we will correct it.